I think WSJ got to play the role where they finally pull the trigger on this company, to help it move along to its demise. Sometimes you hope the management and the board get the message and unwind things when the reality shows you that that particular game is done. And if they don't, then somebody has to come along and provide the kick.

Theranos is done, for all intents and purposes: no proven new technology and nothing interesting at all on the business execution side. Just pure founder ambition and aggressive PR/marketing. Not enough to string things along too much.